3.0
29 Oct 2020
Anonymous employee
Former employee
Paris
Recommend
CEO approval
Business outlook
Pros
Solid pharma player, multiple health care lines of business, open to move people around the world.
Cons
Always trying to engineer a complex org structure. More departmental focus than customer focus, talks about existing silos but doesn't engage in clearly adopting a go to market, customer centric approach beyond speech. Wants to change, but only slowly and gradually. At the top, the French nationality prevails more than it should - no intent to change this bias. On gender balance, there is a real agenda.